SUMMARY Overall laboratory reproducibility for the Ames Seralyzer and plasma potassium test strips was less than 4% within the plasma reference range; and linearity extended from 2-1 to 10 2 mmol/l. Neither bilirubin nor lipaemia interfered in the analysis and selectivity for potassium over sodium was 450:1. Laboratory comparison with automated flame photometry and an indirect ion selective electrode showed a Seralyzer bias of + 010 (± 25D 0-26) and + 0 11 (0.27) mmol/ 1. Against flame photometry, comparison of analyses by six doctors from a coronary care unit and four nurses from a renal dialysis unit showed smaller positive biases (0-06 and 0-02 mmol/l) but substantially larger error ranges (0 43 and 0 55 mmol/l, respectively). Some 49% of the nurses' and 37% of the doctors' results differed from laboratory values by more than 0-2 mmol/l.
The use of a solid phase technique for determining potassium concentration on the Ames Seralyzer reflectance photometer was first described by Charlton et al. ' The method has since been further developed and now offers a novel approach to the measurement of plasma potassium that is potentially simple and speedy. This study was undertaken to determine whether the potassium test strip and reflectance unit would yield reproducible results comparable with those of conventional laboratory methods, both when the system was used by an experienced analyst in the laboratory and when used in clinical units by medical and nursing staff.
Material and methods

REFLECTANCE PHOTOMETER AND POTASSIUM TEST STRIPS
The Seralyzer (Ames Division, Miles Laboratories, USA) is a portable benchtop reflectance photometer controlled by a microprocessor, the principles of which have been described elsewhere.2 The instrument may be used for a wide variety of analyses by simply changing the plug-in test module and strips in use.
The reaction on the potassium strip is based on a Accepted for publication 24 September 1986 colorimetric, ionophore mediated, cation-proton exchange between an aqueous and an organic phase.
The reagent area of the disposable strips consists of a paper matrix impregnated with the organic phase and the dried ingredients of the aqueous phase bonded to a bar coded plastic support strip.
When 30 p1 of a three-fold aqueous plasma dilution is pipetted on to the test area, the buffer ingredients are dissolved and the aqueous phase reconstituted. Fourteen samples previously analysed on the unit with a potassium range of 4.10-6 10 mmol/l were returned for analysis as coded unknowns. The resultant paired data gave a coefficient of variation for the replication of 5 4%.
CORONARY CARE UNIT
The system was used by six doctors. Table 3 shows the control serum results. Samples from 69 acute chest pain admissions analysed by the doctors showed a small association between intermethod differences and averages (r = 0-27, n = 69, p = 0-05 (table 5) ). Overall Seralyzer bias was +0-06 mmol/l and the 03  04  05  Incidence  1  2  3  3  6  6  3  6  5  5  2  1   Table 5 Differences in results between Seralyzer and SMA flame when used by doctors 
+ 0.43 mmol/l. Consistent operator bias was evident for only one doctor whose results averaged 0 25 mmol/l in excess of SMA flame values. A single result from the Seralyzer was recorded as < 2-0 mmol/l, but in the laboratory the potassium was found to be 4.5 mmol/l. Subsequent reanalysis of the sample on the Seralyzer as a coded unknown produced a result of 4 61 mmol/l. The initial low result had been obtained when an incorrect dilution had been used.
Seventeen samples previously analysed on the unit with a potassium range of 3.28-5.50 mmol/l were returned for analysis as coded unknowns. The resultant paired data gave a coefficient of variation for the replication of 4.8%. Discussion
One of the principal considerations, when comparing a new analytical method against routinely used techniques, is that it should have a suitable working range; be free of potential interference from endogenous substances; and be adequately reproducible. The method must also be capable of yielding results with acceptable bias and with a degree of reliability appropriate to specific clinical applications.
The apparent dynamic range of the system was clinically relevant as plasma potassium concentrations below 2 mmol/l are only rarely found, and concentrations of 10 mmol/l are most certainly incompatible with human life. A negative bias, however, was noted below 2.7 mmol/l. Neither lipaemia nor icterus caused significant interference with potassium measurement, and the selectivity of the ionophore was sufficient to obviate sodium interference even at the extremes of the pathological range likely to be found in human plasma.
For judging the precision of the method, several criteria are available. Using Tonks's rule,4 the allowable limits of error should not exceed a quarter of the reference interval, yielding an acceptable coefficient of variation for this determination of up to 5.4%. Alternatively, Barnetts derived medically significant coefficient of variations from a synthesis of opinions of clinicians and laboratory specialists to arrive at a figure of 4-2% for this determination. According to both sets of criteria, reproducibility of strip results in the hands of an experienced analyst in the laboratory was of acceptable proportions. Control analyses performed by the nurses and doctors were also within these limits, but both groups could satisfy only the Tonks's limits for repeat analysis of samples from patients. More rigorous goals for precision have been advocated,6 both for serial sample testing in the same subject (coefficient of variation = 3%), and for single sample analysis (coefficient of variation = 2 5%). While these levels of performance were attainable with flame emission and the ion selective electrode, they were not achieved by any of the users of the Seralyzer system. For all operators, the Seralyzer had an overall positive bias of up to 0 11 mmol/l. This is most likely to reflect differences in the sources of the calibrating materials, which were the respective instrument manufacturers' products. The error seen in Seralyzer results was least in the hands of an experienced analyst, for whom 80% of the results did not differ from the laboratory value by more than 0-2 mmol/l. For the doctors and nurses alike, however, the error was substantially larger; almost half the nurses' results and over one third of the doctors' results differed from the laboratory value by more than 0.2 mmol/l. I conclude that the Seralyzer dry reagent strip for plasma potassium determination has been shown to be usable by an experienced analyst; produces results that are both comparable with conventional laboratory techniques and generally sufficiently reliable for clinical use. Plasma potassium determinations performed by clinical staff using the Seralyzer were more variable and, although they might be used to indicate the possible need for therapeutic measures, they could not be used for precise monitoring of such treatment.
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